Conference Calendar - The 88th EAS Congress

All times are in CET (Central European Time)

Displaying One Session

View

Industry Sponsored Session

Not included in the main CME-CPD of the event

Session Type

Industry Sponsored Session

Room

Industry session hall

Date

07.10.2020, Wednesday

Session Time

16:00 - 17:30

Session Description

•To discuss the importance of achieving LDL-C goals in uncontrolled patients;•To highlight the challenges to achieve guideline goals in daily clinical practice;•To emphasize the importance of combining lipid lowering therapies;•To discuss new therapeutic options to intensify lipid lowering therapies.

Session Ticket

Session Evaluation

Please enter to our survey here

Session Evaluation

Option 1

Watch Stream
Session Webcast

Session Webcast

[{"name":"Welcome and introduction","mode":"playlist","public":true,"info":{"id":1739,"presentation":"Welcome and introduction","session":"Not included in the main CME-CPD of the event","presenter":"Alberico Luigi Catapano, Italy","photo":""},"playlist":[{"name":"Welcome and introductionWelcome and introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/Video 1 - EAS Virtual Congress - Prof Catapano.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/24\/Video 1 - EAS Virtual Congress - Prof Catapano.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/2492AEED.jpg","data":[],"tracks":[]}]},{"name":"New LDL-C goals: Practical implications for the management of patients with residual risk.","mode":"playlist","public":true,"info":{"id":1740,"presentation":"New LDL-C goals: Practical implications for the management of patients with residual risk.","session":"Not included in the main CME-CPD of the event","presenter":"Fran\u00e7ois Mach, Switzerland","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"New LDL-C goals: Practical implications for the management of patients with residual risk.","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/Video 2 - EAS Virtual Congress - Prof Mach.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/24\/Video 2 - EAS Virtual Congress - Prof Mach.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/AAD26D72.jpg","data":[],"tracks":[]}]},{"name":"Combination of lipid lowering therapies: Evidence from Mendelian randomization studies","mode":"playlist","public":true,"info":{"id":1741,"presentation":"Combination of lipid lowering therapies: Evidence from Mendelian randomization studies","session":"Not included in the main CME-CPD of the event","presenter":"Brian A. Ference, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/2139.jpg"},"playlist":[{"name":"Combination of lipid lowering therapies: Evidence from Mendelian randomization studies","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/Video 3 - EAS Virtual Congress - Prof Ference.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/24\/Video 3 - EAS Virtual Congress - Prof Ference.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/FAFC3F82.jpg","data":[],"tracks":[]}]},{"name":"On the horizon: Novel options for the combination of LDL-C lowering therapies","mode":"playlist","public":true,"info":{"id":1742,"presentation":"On the horizon: Novel options for the combination of LDL-C lowering therapies","session":"Not included in the main CME-CPD of the event","presenter":"Ulrich Laufs, Germany","photo":""},"playlist":[{"name":"On the horizon: Novel options for the combination of LDL-C lowering therapies","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/Video 4 - EAS Virtual Congress - Prof Laufs.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/24\/Video 4 - EAS Virtual Congress - Prof Laufs.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/B0432A0C.jpg","data":[],"tracks":[]}]},{"name":"Panel discussion & Conclusion","mode":"playlist","public":true,"info":{"id":1743,"presentation":"Panel discussion & Conclusion","session":"Not included in the main CME-CPD of the event","presenter":"Alberico Luigi Catapano, Italy, Fran\u00e7ois Mach, Switzerland, Ulrich Laufs, Germany","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/Add on to take back control Combining lipid-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/24\/Add on to take back control Combining lipid-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/24\/EDE0A2.jpg","data":[],"tracks":[]}]}]